Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-bisabolol for Onychomycosis
NCT04940520Phase 1Completed
- Sponsor
- Universidade do Vale do Sapucaí
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of alpha-bisabolol in onychomycosis (3 arms), sponsored by Universidade do Vale do Sapucaí. Primary endpoint: Injury area analysis at 2 months. Started Jun 2020; status: completed.
02
Drugs
alpha-bisabolol
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT04940520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940520.